Botulinum Toxin Applications in Overactive Bladder Symptoms Secondary to Neurological Diseases

被引:2
|
作者
Kulaksizoglu, Haluk [1 ]
机构
[1] Selcuk Univ, Selcuklu Tip Fak, Urol Anabilim Dali, Konya, Turkey
来源
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2010年 / 47卷
关键词
Botulinum toxin injections; incontinence; overactive bladder; neurogenic bladder; NEUROGENIC DETRUSOR OVERACTIVITY; URINARY-TRACT DYSFUNCTION; GENE-RELATED PEPTIDE; SPINAL-CORD-INJURY; A TOXIN; MULTIPLE-SCLEROSIS; DIABETES-MELLITUS; MANAGEMENT; INJECTIONS; DIAGNOSIS;
D O I
10.4274/npa.y5931
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Overactive bladder symptoms and incontinence are major problems that disturb both the patients' and their caregivers quality of life. Anticholinergic therapies are effective, but have restrictions in their use in neurogenic overactive bladder patients due to high side effects inidence, interference with the disease process itself or the treatment. Botulinum toxin applications into the detrusor muscles have been more popular recently since there is minimal side effect, high efficency, pure local effect that prevents detoriation of the disease process or interfere with medical therapies. This review gives the latest data on the use of botulinum toxin injection therapy for neurogenic overactive bladder patients. (Archives of Neuropsychiatry 2010; 47 Supplement: 44-7)
引用
收藏
页码:44 / 47
页数:4
相关论文
共 50 条
  • [41] Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going
    Sahai, Arun
    Khan, Mohammad S.
    Gregson, Norman
    Smith, Kenneth
    Dasgupta, Prokar
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (07): : 379 - 386
  • [42] Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder
    Bentaleb, Y.
    Castel-Lacanal, E.
    Sallusto, F.
    De Boissezon, X.
    Malavaud, B.
    Marque, P.
    Rischmann, P.
    Game, X.
    PROGRES EN UROLOGIE, 2008, 18 (07): : 449 - 455
  • [43] Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms
    Marcelissen, T. A. T.
    Rahnama'i, M. S.
    Snijkers, A.
    Schurch, B.
    De Vries, P.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (02) : 307 - 311
  • [44] Botulinum toxin for neurogenic bladder dysfunction
    Schulte-Baukloh, H.
    UROLOGE, 2012, 51 (02): : 198 - 203
  • [45] Botulinum toxin for neurogenic bladder dysfunction
    Schulte-Baukloh, H.
    UROLOGE, 2012, 51 (02): : 198 - 203
  • [46] Botulinum toxin A should not be first-line therapy for overactive bladder
    Carr, Lesley K.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (03): : 204 - 205
  • [47] Intravesical botulinum toxin for overactive bladder syndrome without detrusor overactivity
    Jackson, B. L.
    Burge, F.
    Bronjewski, E.
    Parkinson, R. J.
    JOURNAL OF CLINICAL UROLOGY, 2012, 5 (04) : 169 - 173
  • [48] Treatment of overactive bladder with botulinum toxin type B: A pilot study
    Dennis Dykstra
    Al Enriquez
    Michael Valley
    International Urogynecology Journal, 2003, 14 (6) : 424 - 426
  • [49] Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
    Wada, Naoki
    Ishikawa, Mayumi
    Nagabuchi, Masaya
    Makino, Shogo
    Miyauchi, Kotona
    Abe, Noriyuki
    Kakizaki, Hidehiro
    IJU CASE REPORTS, 2022, 5 (05) : 384 - 388
  • [50] Botulinum-A Toxin's efficacy in the treatment of idiopathic overactive bladder
    Moga, Marius Alexandru
    Banciu, Simona
    Dimienescu, Oana
    Bigiu, Nicusor-Florin
    Scarneciu, Ioan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (01) : 76 - 80